Skip to content

The Beilhack Lab

Novel Concepts for Immunotherapy

  • Startseite
  • Research
  • Team
  • Publications
  • Careers
  • Research Networks
  • Funding
  • News
  • Contact
The Beilhack Lab

Mac-Man – Beilhack lab 2025

20. September 2025 beilhack

MAC-MAN - CD47 blocking allows macrophages to ingest alloreactive T cells to control acute GvHD. Heiko Bruns and Andreas Beilhack lab Immunotherapy Program, Würzburg University Hospital, Cancer Immunotherapy Germany

Archives

Recent Posts

  • Mac-Man unchained: A new strategy against Graft-versus-Host Disease
  • Best Poster Award at International Meeting on Pathogenic Fungi
  • Major Progress in the Development of New Medications Against Dangerous Fungal Infections
  • Research award to propel new concepts for cancer therapy
  • Dr. Haroon Shaikh Wins Prestigious EBMT Basic Science Award 2024 for Breakthrough in Graft-Versus-Host Disease Research
  • Innovative antibody design targets TNFR2 for safer, more effective treatments
  • Decoding Two-Way Brain-Gut Communication Unveils New Insights into Neurological Diseases
  • Dr. Stefanie Schwinn Awarded Top Thesis Award
  • Breakthrough in Overcoming Immune Therapy Resistance
  • Linoleic Acid Unleashes Potent Antitumor Immunity in CD8+ T Cells
Impressum